Education History
| Undergraduate |
Yale University |
BS |
|---|---|---|
| Professional Medical |
New York University, New York |
MD |
| Fellowship |
Harvard Medical School |
Clinical Fellow |
| Internship/Residency |
Beth Israel-Deaconess Medical Center |
Intern/Resident |
| Internship/Residency |
University of California, San Francisco |
Intern/Resident |
| Fellowship |
University of California, San Francisco |
Clinical Fellow |
| Research Fellow |
University of California, San Francisco |
Research Fellow |
| Other Training |
Institute for Health Care Delivery Research, Intermountain Healthcare |
|
| Certification |
Health Management Academy |
Certification |
| Certification |
University of Utah David Eccles School of Business, Intermountain Health |
Certification |
| Certification |
Stanford University Graduate School of Business |
Certificate |
Selected Publications
Journal Article
- Horne BD, Joy EA, Hofmann MG, Gesteland PH, Cannon JB, Lefler JS, Blagev DP, Korgenski EK, Torosyan N, Hansen GI, Kartchner D, Pope CA 3r (2018). Short-Term Elevation of Fine Particulate Matter Air Pollution and Acute Lower Respiratory Infection. American journal of respiratory and critical care medicine, 198(6), 759-766.
- Blagev DP, Collingridge DS, Rea S, Press VG, Churpek MM, Carey K, Mularski RA, Zeng S, Arjomandi M (2018). Stability of Frequency of Severe Chronic Obstructive Pulmonary Disease Exacerbations and Health Care Utilization in Clinical Populations. COPD, 5(3), 208-220.
- Blagev DP, Callahan SJ, Harris D, Collingridge DS, Hopkins RO, Eve JR, Waddoups L, Aston V, Brown S, Lanspa M (2022). Prospectively Assessed Long-Term Outcomes of Patients with E-Cigarette- or Vaping-associated Lung Injury. Annals of the American Thoracic Society, 19(11), 1892-1899. (Read full article)
- Blagev DP, Lanspa M (2020). Autopsy insights from the EVALI epidemic. The Lancet. Respiratory medicine, 8(12), 1165-1166. (Read full article)
- Hegewald MJ, Horne BD, Trudo F, Kreindler JL, Chung Y, Rea S, Blagev D (2020). Blood Eosinophil Count and Hospital Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. International journal of chronic obstructive pulmonary disease, 15, 2629-2641. (Read full article)
- Blagev DP, Collingridge DS, Rea S, Carey KA, Mularski RA, Zeng S, Arjomandi M, Press V (2020). Laboratory-based Intermountain Validated Exacerbation (LIVE) Score stability in patients with chronic obstructive pulmonary disease. BMJ open respiratory research, 7(1), (Read full article)
- Blagev DP, Harris D, Dunn AC, Guidry DW, Grissom CK, Lanspa M (2019). Clinical presentation, treatment, and short-term outcomes of lung injury associated with e-cigarettes or vaping: a prospective observational cohort study. Lancet (London, England), 394(10214), 2073-2083. (Read full article)
- Horne BD, Joy EA, Hofmann MG, Gesteland PH, Cannon JB, Lefler JS, Blagev DP, Korgenski EK, Torosyan N, Hansen GI, Kartchner D, Pope CA 3r (2018). Short-Term Elevation of Fine Particulate Matter Air Pollution and Acute Lower Respiratory Infection. American journal of respiratory and critical care medicine, 198(6), 759-766. (Read full article)
- Blagev DP, Collingridge DS, Rea S, Press VG, Churpek MM, Carey K, Mularski RA, Zeng S, Arjomandi (2018). Stability of Frequency of Severe Chronic Obstructive Pulmonary Disease Exacerbations and Health Care Utilization in Clinical Populations. Chronic obstructive pulmonary diseases (Miami, Fla.), 5(3), 208-220. (Read full article)
- Blagev DP, Collingridge DS, Rea S, Horne BD, Press VG, Churpek MM, Carey KA, Mularski RA, Zeng S, Arjomandi (2018). The Laboratory-Based Intermountain Validated Exacerbation (LIVE) Score Identifies Chronic Obstructive Pulmonary Disease Patients at High Mortality Risk. Frontiers in medicine, 5, 173. (Read full article)
- Stemmer A, Shadmi R, Bregman-Amitai O, Chettrit D, Blagev D, Orlovsky M, Deutsch L, Elnekave (2020). Using machine learning algorithms to review computed tomography scans and assess risk for cardiovascular disease: Retrospective analysis from the National Lung Screening Trial (NLST). PloS one, 15(8), e0236021. (Read full article)
- Linares-Perdomo O, Hegewald M, Collingridge DS, Blagev D, Jensen RL, Hankinson J, Morris A (2016). Comparison of NHANES III and ERS/GLI 12 for airway obstruction classification and severity. The European respiratory journal, 48(1), 133-41. (Read full article)
Review
- Aberegg SK, Maddock SD, Blagev DP, Callahan S (2020). Diagnosis of EVALI: General Approach and the Role of Bronchoscopy. Chest, 158(2), 820-827. (Read full article)
Editorial
- Blagev D (2023). Comparison Among Different Inhalers in COPD: The Differences Are Too Big and Too Small, and It Matters. Chest, 163(4), 731-732. (Read full article)
- Callahan SJ, Lanspa MJ, Blagev D (2021). Is COVID-19 masking the ongoing youth vaping crisis?. Expert review of respiratory medicine, 15(9), 1089-1091. (Read full article)
- Press VG, Gershon AS, Sciurba FC, Blagev D (2020). Concerns About Coronavirus Disease-Related Collateral Damage for Patients With COPD. Chest, 158(3), 866-868. (Read full article)
- Blagev D (2020). Better with Time: Reductions in Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society, 17(6), 684-685. (Read full article)
- Blagev D (2020). No man is an island: e-cigarette, or vaping, associated lung injury in Europe. The European respiratory journal, 55(2), (Read full article)
- Blagev (2015). Evaluation of pulmonary complaints in the emergency department. Time to go back to the basics. Annals of the American Thoracic Society, 12(5), 625-6. (Read full article)
Letter
- Lanspa MJ, Blagev DP, Callahan S (2021). Use of e-Cigarettes for Smoking Cessation. JAMA, 325(10), 1006. (Read full article)
- Callahan SJ, Harris D, Collingridge DS, Guidry DW, Dean NC, Lanspa MJ, Blagev D (2020). Diagnosing EVALI in the Time of COVID-19. Chest, 158(5), 2034-2037. (Read full article)